Literature DB >> 14415617

Reduction of 5-fluorouracil toxicity in man with retention of anticancer effects by prolonged intravenous administration in 5 per cent dextrose.

H M LEMON.   

Abstract

Entities:  

Keywords:  GLUCOSE/pharmacology; NEOPLASMS/therapy; URACIL/related compounds

Mesh:

Substances:

Year:  1960        PMID: 14415617

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  4 in total

1.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

2.  Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.

Authors:  D Raghavan; J Bishop; D Sampson; J Grygiel; R Woods; A Coates; R Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 3.  Cellular pharmacology of fluorinated pyrimidines in vivo in man.

Authors:  J S Kovach; R W Beart
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 4.  Continuous 5-fluorouracil in the treatment of breast cancer.

Authors:  D A Cameron; H Gabra; R C Leonard
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.